Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

CMND

$6.226.31%0.3689

Clearmind Medicine Inc (CMND)

Date: O: H: L: C: Vol:

Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten

A 25,300-share holder reports a below-5% stake in Clearmind Medicine (CMND). - Stock Titan

Psyence Biomedical Ltd. (PBM) Stock Price, News, Quote & History - Yahoo! Finance Canada

SciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance UK

SciSparc Ltd. (SPRC) Stock Price, News, Quote & History - Yahoo! Finance Canada

SciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance Singapore

Clearmind Medicine (CMND) Slips 2.49% to $6.26, Pivoting Inside a Tight $5.95–$6.57 Band - Composite Profile - https://www.dars.gov.et/

At 90% of principal, Clearmind Medicine (CMND) plans a sale of promissory notes. - Stock Titan

Sagimet Biosciences Inc. (SGMT) stock price, news, quote and history - Yahoo Finance Singapore

Clearmind Medicine Company Profile & Introduction - Moomoo

Net loss narrows to $6.05M, but SciSparc (SPRC) raises substantial doubt about continuing operations. - Stock Titan

Fractions will round up in Clearmind Medicine (NASDAQ: CMND)'s October 5 reverse split. - Stock Titan

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split - Yahoo Finance

Three patent applications pair LSD, ketamine and ibogaine with a proprietary compound. - Stock Titan

Stickit Technologies Announces Corporate Update: Leadership Appointments, Capital Restructuring & Loan Acquisition, And Update Of Intellectual Property Portfolio - TradingView

Clearmind enrolls first AUD patients in CMND-100 trial - grafa.com

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial - The Manila Times

Two patients become the first to receive Clearmind's potential treatment for alcohol use disorder. - stocktitan.net

Proposed Nasdaq threshold could threaten Clearmind (NASDAQ: CMND) listing - Stock Titan

Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo

Charging Robotics Inc. Sells Majority Stake in Charging Israel to Clearmind Medicine for $2.5M (OTC: CHEV) - Kalkine Media

Clearmind Medicine Announces Yale IRB Approval to Begin Patient Recruitment for CMND-100 Phase I/II Trial in Alcohol Use Disorder - Quiver Quantitative

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results - The Manila Times

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results - marketscreener.com

All 24 trial participants completed treatment with no serious adverse events. Yale can now recruit. - Stock Titan

Clearmind to acquire 51% stake in EV charging firm for $2.5M By Investing.com - Investing.com Australia

Clearmind Medicine to Acquire Majority Stake in Charging Robotics for $2.5 Million - marketscreener.com

CMND Stock Slides As Clearmind Medicine Tightens Cash Belt - StocksToTrade

Clearmind to acquire 51% stake in EV charging firm for $2.5M By Investing.com - Investing.com South Africa

Clearmind Tumbles on Buying into Charging Robotics - Baystreet.ca

Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million - Yahoo Finance

Clearmind Medicine Stock Slides Friday: What's Happening? - Benzinga

CMND Stock Slides As Traders Eye Key Support Levels - timothysykes.com

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis - The Manila Times

CMND Stock Pops As Clearmind Advances AUD Drug To Phase IIa - timothysykes.com

Clearmind to acquire 51% stake in EV charging firm for $2.5M - Investing.com UK

Clearmind Medicine Inc. (CMND) moves into EV wireless charging with a controlling deal - Stock Titan

Clearmind Medicine ลงนามในข้อตกลงขั้นสุดท้ายเพื่อเข้าซื้อหุ้น 51% ในบริษัทระบบชาร์จไร้สายสำหรับระบบจอดรถอัตโนมัติและรถแท็กซี่ไร้คนขับ (Robotaxis) - Moomoo

A biotech plans to buy most of a wireless charging company for robotaxis - Stock Titan

Clearmind Tumbles on Buying into Charging Robotics - Baystreet.ca

Debt-for-share swap at $1 sets new floor at Clearmind (CMND) - Stock Titan

Clearmind Medicine Inc. (CMND) Stock: Jumps Nearly 10% as Phase IIa AUD Trial Begins - Blockonomi

Clearmind starts Phase IIa AUD trial of CMND-100 - Stock Titan

Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled - The Manila Times

Clearmind Medicine Announces Initiation of Phase IIa Trial for CMND-100 in Alcohol Use Disorder - Quiver Quantitative

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Clearmind Medicine (CMND) Slips 2.76% to $1.76, Holds Above Key Support at $1.67 - Hedge Fund Favorites - siam.in

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation - The Manila Times

NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation - NewMediaWire

SciSparc: NeuroThera-Clearmind Collaboration Advances - GlobeNewswire

Clearmind (CMND) Market: Adds 0.87% to Close at $1.74; Chart Watch: Support at $1.65 and Resistance at $1.83 Frame the Range in the Latest Session - Volume Rate Change - vinanet.vn

Ähnlich wie CMND

NVCT$18.480.48%

ZVRA$10.280.77%